ZENTALIS PHARMACEUTICALS INC (ZNTL) — institutional ownership
124 funds reported holding ZENTALIS PHARMACEUTICALS INC in their latest 13F filings, worth $239M in total (CUSIP 98943L107).
Largest holders
- Squadron Capital Management LLC — $20.0M
- 5AM Venture Management, LLC — $19.1M
- BlackRock, Inc. (BLK) — $18.2M
- TWO SIGMA INVESTMENTS, LP — $14.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $13.8M
- ACADIAN ASSET MANAGEMENT LLC — $13.0M
- CITADEL ADVISORS LLC — $11.3M
- RENAISSANCE TECHNOLOGIES LLC — $7.80M
- Opaleye Management Inc. — $6.85M
- ORBIMED ADVISORS LLC — $6.74M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Izzy Englander portfolio (Millennium Management)
- D. E. Shaw portfolio (D. E. Shaw & Co.)